Yachiyo, Japan

Akihiro Shibata




Average Co-Inventor Count = 6.9

ph-index = 5

Forward Citations = 79(Granted Patents)


Location History:

  • Narashino, JP (1987 - 1989)
  • Yachiyo, JP (1994 - 1999)
  • Chiba, JP (2004)

Company Filing History:


Years Active: 1987-2004

Loading Chart...
Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents

Title: Akihiro Shibata: Innovator in Quinolone Carboxylic Acid Compositions

Introduction

Akihiro Shibata is a prominent inventor based in Yachiyo, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of quinolone carboxylic acid compositions. With a total of 10 patents to his name, Shibata's work has had a considerable impact on the treatment of ocular and periocular infections.

Latest Patents

Shibata's latest patents focus on quinolone carboxylic acid formulations. These formulations are designed for the treatment of ocular and periocular infections. His inventions also include sustained release compositions that comprise specific quinolone carboxylic acid compounds. The methods of preparing these compositions are also a key aspect of his recent work.

Career Highlights

Throughout his career, Akihiro Shibata has worked with notable companies, including Ss Pharmaceutical Co., Ltd. His innovative approaches and dedication to research have led to advancements in pharmaceutical treatments.

Collaborations

Shibata has collaborated with esteemed colleagues such as Takemitsu Asaoka and Hideaki Matsuda. These partnerships have fostered a collaborative environment that enhances the development of new pharmaceutical solutions.

Conclusion

Akihiro Shibata's contributions to the field of pharmaceuticals, particularly through his patents on quinolone carboxylic acid compositions, highlight his role as a significant innovator. His work continues to influence the treatment of infections, showcasing the importance of innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…